Thromboelastometry detects enhancement of coagulation in blood by emicizumab via intrinsic pathway

Haemophilia. 2021 Jul;27(4):e571-e574. doi: 10.1111/hae.14330. Epub 2021 May 14.

Authors

Timea Szanto^{1

2}, Ines Vaide³, Annukka Jouppila⁴, Marja Lemponen², Riitta Lassila^{1

2}

Affiliations

¹ Research Program Unit in Systems Oncology, Faculty of Medicine, Helsinki University, Helsinki, Finland.
² Comprehensive Cancer Center, Department of Hematology, Unit of Coagulation Disorders, Helsinki University Hospital, Helsinki, Finland.
³ Department of Hemato-Oncology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
⁴ Clinical Research Institute HUCH, Helsinki, Finland.

PMID: 33988297
DOI: 10.1111/hae.14330

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Bispecific*
Antibodies, Monoclonal, Humanized
Blood Coagulation
Humans
Thrombelastography*

Substances

Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
emicizumab

Grants and funding